TetraLogic Pharmaceuticals Corp (TLOG)

[mick]

Earnings and Valuation
This table compares Tetralogic Pharmaceuticals Corp and its competitors top-line revenue, earnings per share and valuation.
Gross Revenue EBITDA Price/Earnings Ratio
Tetralogic Pharmaceuticals Corp N/A -$21.14 million -0.03
Tetralogic Pharmaceuticals Corp Competitors $224.58 million $57.96 million -1.13

https://www.truebluetribune.com/2017/10/31/head-to-head-analysis-tetralogic-pharmaceuticals-corp-tlog-its-peers.html

Tetralogic Pharmaceuticals Corp’s competitors have higher revenue and earnings than Tetralogic Pharmaceuticals Corp. Tetralogic Pharmaceuticals Corp is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.